Periscope Capital’s DermTech, Inc. Common Stock DMTK Stock Holding History

Periscope Capital’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-271,900	Closed	-$5.55M	–	189
2018 Q4	$5.55M	Buy	271,900 +95,650	+54%	+$1.94M	1.04%	32
2018 Q3	$3.57M	Hold	176,250	–	–	0.68%	59
2018 Q2	$3.51M	Sell	176,250 -150	-0.1%	-$2.98K	0.75%	51
2018 Q1	$3.48M	Buy	176,400 +50,150	+40%	+$983K	0.81%	45
2017 Q4	$2.46M	Buy	126,250 +25,250	+25%	+$492K	0.61%	61
2017 Q3	$1.97M	Buy	+101,000	New	+$1.97M	0.67%	48

Other funds holding DMTK

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Periscope Capital's DMTK Position: Q1 2019 in Review

Periscope Capital sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2019, closing a stake of 271,900 shares — an estimated $5.55M sold.

Periscope Capital first reported a position in DMTK in Q3 2017 and held it in 6 quarters. The position peaked at $5.55M in Q4 2018. 5 funds tracked by Wall St. Rank hold DMTK as of Q1 2019.

Periscope Capital reported no remaining DermTech, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Periscope Capital sold 271,900 DermTech, Inc. Common Stock shares in Q1 2019, an estimated $5.55M.
Periscope Capital first reported a position in DermTech, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
Periscope Capital's DermTech, Inc. Common Stock position peaked at $5.55M in Q4 2018.
5 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2019.

Based on Periscope Capital's 13F filing for Q1 2019, filed 2 May 2019.